Asphalion starts a new collaboration with Maria Molist

Asphalion starts a new collaboration with Maria Molist

Asphalion is very pleased to announce the start of the collaboration with Maria Molist (director/pharmacovigilance consultant at MMPV) for the provision of pharmacovigilance/regulatory services in the UK.

Maria Molist studied Pharmacy at the University of Santiago de Compostela (Spain) and holds a Master’s Degree in Medical Microbiology from the University of Surrey (UK). Maria moved to the UK in 1991 and has 19 years experience in the pharmaceutical industry, primarily in the area of pharmacovigilance/drug safety. During her career Maria has held the role of (EU) Deputy QPPV in two occasions and of Chair of a Drug Safety Analysis group.

Her years in the industry have allowed her to acquire extensive knowledge in all aspects of pharmacovigilance including implementation of new legislation, audit and inspections and integration of mergers and acquisitions.

AsphaNews 2020 | First Newsletter of the year
Asphalion is attending the SBR H2020 project kick-off meeting